Hypercalcaemia Due to Hyperparathyroidism in a Patient with Chronic Renal Failure and Renal Carcinoma

Total Page:16

File Type:pdf, Size:1020Kb

Hypercalcaemia Due to Hyperparathyroidism in a Patient with Chronic Renal Failure and Renal Carcinoma J Clin Pathol: first published as 10.1136/jcp.32.3.234 on 1 March 1979. Downloaded from Journal of Clinical Pathology, 1979, 32, 234-239 Hypercalcaemia due to hyperparathyroidism in a patient with chronic renal failure and renal carcinoma J. J. SZWED, L. J. GOTT, R. E. LEMPKE, AND IN SOOK SEO From the Departments of Medicine, Surgery, and Pathology, Clowes Research Laboratories, Wishard Memorial Hospital, Indiana University Medical Center, Indianapolis, Indiana 46202, USA SUMMARY A 65-year-old woman with a history of a left heminephrectomy for renal carcinoma developed hypercalcaemia 11 years after the operation. The same kidney was found to contain a recurrent renal carcinoma. After the radical nephrectomy of the left kidney, hypercalcaemia remitted but reappeared 11 months later. The right kidney was small but functioned at a level of creatinine clearance of 10-15 ml/min. Metastatic work-up was negative, and secondary causes ofhypercalcaemia were excluded. A neck exploration revealed a parathyroid adenoma. With parathyroid resection the serum calcium declined to normal, and the risk of hypercalcaemic nephropathy in the remaining kidney was precluded. copyright. Hypercalcaemia is a common manifestation of Case report malignancy of numerous organs, including the kid- ney (Albright and Reifenstein, 1948; Connor et al., The patient is a woman who was found to have a 1956; Plimpton and Gellhorn, 1956; Gold and carcinoma of the left kidney during evaluation of in 1965 at age 54. The physical Shnider, 1959; Lucas, 1960; David et al., 1963; vaginal prolapse http://jcp.bmj.com/ Noenickx et al., 1962; Moses and Spencer, 1963; examination was normal except for obvious vaginal Samuelsson and Werner, 1963; Goldberg et al., prolapse. The full blood count, urine analysis, 1964). Primary hyperparathyroidism is a relatively serum electrolytes, serum calcium and phosphate, common disorder, usually benign, with a frequency and creatinine clearance were normal. She under- of 1 case per 1000 persons per year. The most went segmental resection of the left kidney (Fig. 1). common manifestation of this disorder is hyper- On microscopic examination the tumour was a renal calcaemia (Thorn et al., 1977). The association of carcinoma. There were no metastases nor was there renal carcinoma and hyperparathyroidism in the evidence of local invasion. At the time of the on September 26, 2021 by guest. Protected same patient is uncommon and has rarely been operation the patient was described as being quite diagnosed before the death of the patient (Bernstein 'irritable' by several physicians. She was discharged et al., 1965; Salama et al., 1971; Nemoto et al., from hospital and followed with yearly intravenous 1977). pyelograms. This report describes a patient with chronic renal In July 1976, 11 years after the first operation, she failure, who had had a total left nephrectomy for a was found to have progressive dilatation and club- recurrent renal carcinoma accompanied by hyper- bing of upper pole calyces, and an angiogram (Fig. calcaemia and, 11 months later, was found to 2) showed a 7 x 4 x 5 cm tumour mass involving have recurrent hypercalcaemia. The recurrent hyper- one-half to two-thirds of the upper pole of the left calcaemia was not due to recurrent renal carcinoma kidney. The right kidney appeared to be small but but rather to a parathyroid adenoma. After removal without gross tumour involvement. Investigation of a parathyroid adenoma the hypercalcaemia revealed that the haemoglobin was 12-0 g/dl, WBC remitted. 7-8 x 109/l with a normal differential. The urine was clear with pH 6-0 and SG 1 -010; there were 10-20 RBCs/hpf, 5-10 WBCs/hpf, and no casts nor Received for publication 5 September 1978 bacteria. Urine cultures were negative on three 234 J Clin Pathol: first published as 10.1136/jcp.32.3.234 on 1 March 1979. Downloaded from Hypercalcaemia due to hyperparathyroidism in a patient with chronic renalfailure 235 Ra 11 I Llo-If - E 31 8~~~~~~~~ ---_- p4 04 1000- 800 916 900 600 800 800 *E100 * -We ZW 50 \ Q-4 copyright. 11/65 7/76 8/76 8 6 9/76 9/76 5/77 8/77 8/77 9/77 10/77 Fig. 1 A graph depicting the patient's course by following serum calcium, phosphate, PTH, and creatinine clearance. separate occasions. Serum electrolytes were: sodium disease. Postoperatively the urine output from ranged http://jcp.bmj.com/ 135 mEq/l (135 mmol/l), potassium 4-1 mEq/l (4-1 50 to 100 ml/day for 48 hours and then rose to 1500 mmol/l), chloride 99 mEq/l (99 mmol/l), carbon- ml/day; creatinine clearance stabilised at 10-15 ml[ dioxide combining power 26 mEq/l (26 mmol/l). min during the next 10 days. The serum calcium Total serum proteins 6-3 g/dl (63 g/l) with albumin level was 9 0 mg/dl (2 25 mmol/l) and serum phos- 3-6 g/dl (36 g/I). Serum calcium levels of 11 -2 mg/dl phate was 3-0 mg/dl (0 97 mmol/l) at discharge in (2-8 mmol/l), 11 -0 mg/dl (2-75 mmol/l), and 11 -5 mg/ October 1976. dl (2-88 mmol/l) (normal range: 8&4-10-0 mg/dl; Before operation in 1976 the patient's parathyroid 2 1-2-5 mmol/l) were found with corresponding serum hormone level had been 916 pg/ml. Postoperatively, on September 26, 2021 by guest. Protected phosphate levels of 3 2 mg/dl (1 03 mmol/l), 3 0 mg/ the level declined to 800 pg/ml and has remained at dl (0 97 mmol/l), and 2-8 mg/dl (0 90 mmol/l). The approximately the same elevated level to the present ionised serum calcium was 2-54 mEq/l (1 27 mmol/l) time. While the patient's renal function gradually preoperatively, falling to 2-22 mEq/l (1 11 mmol/l) improved with hypertrophy of the remaining kidney, postoperatively (normal range: 1-78-2-28 mEq/l; the serum calcium began to rise again and in August 0-89-1-14 mmol/l), creatinine clearance was 100 ml/ 1977 reached values of 10-5-11l5 mg/dl (2-63-2-88 min. All other laboratory or radiological investiga- mmol/l); the ionised calcium was also elevated at tions were normal. 2-60 mEq/l (1 -3 mmol/l). Initially, the hypercalcaemia The remainder of the left kidney was resected in was thought to be due to the renal carcinoma, but September 1976 and found to contain a well- the postoperative rise in 1977 suggested that the- encapsulated neoplasm measuring 5-5 x 6-0 cm. On patient had a recurrence of tumour or had another, section it had a yellow, vascular cut surface with areas occult cause of hypercalcaemia. After another work- of haemorrhagic necrosis and microscopically was up for metastatic neoplasm was found to be negative- composed predominantly of polygonal clear cells radiologically and biochemically, secondary causes- (Fig. 3). No evidence of metastases was found at of hypercalcaemia were evaluated. Bone marrow and operation. The renal vessels and ureter were free of serum protein electrophoresis were both normal and J Clin Pathol: first published as 10.1136/jcp.32.3.234 on 1 March 1979. Downloaded from 236 J. J. Szwed, L. J. Gott, R. E. Lempke, and In Sook Seo Fig. 2 Renal angiogram demonstrating large tumour of the left kidney and the small right kidney. copyright. http://jcp.bmj.com/ 4 A ~~~A on September 26, 2021 by guest. Protected V Fig. 3 Renal cell carcinoma showing typical clear cells with highly vascular 4 7k stroma (Haematoxylin and ~ ~ ~ ~ ~~~~~~~~~~~~~~~~~~~~~~~ eosin x 100). 4~~~~~~~~~~~~~4 4 4.W~~~~~~~~~~~~~~~~44 .A 4rl -1 4 J Clin Pathol: first published as 10.1136/jcp.32.3.234 on 1 March 1979. Downloaded from Hypercalcaemia due to hyperparathyroidism in a patient with chronic renalfailure 237 Fig. 4 Functioning parathyroid adenoma containing chiefcells growing in sheets and glandular pattern (H and E x 100). copyright. excluded the largest group of multiple myelomas, the serum calcium levels returned to the 9-5-100 mg/ that is, secretary myelomas. Thyroid function studies dl (2 38-2 5 mmol/l) range with a serum phosphate were normal. Sarcoidosis was not suggested by either reading 3 0-3 4 mg/dl (0 97-1 10 mmol/l) two months history, physical findings, or radiological examina- after surgery. The patient now feels well, but her tion. The patient was taking no vitamins nor diuretics, irritability persists. Her renal function continues to nor was she ingesting any milk products or antacids improve gradually and her creatinine clearance is http://jcp.bmj.com/ in large quantities to our knowledge. It was, there- now 45 ml/min. fore, concluded that a parathyroid adenoma might be present, although this diagnosis was supported Discussion only by the patient's chronic irritability, noted by many observers, and her hypercalcaemia. The relationship between malignancy and increased Since the renal function was slowly improving parathyroid hormone (PTH) levels can be ascribed with one kidney, it was decided to explore her neck to the production of PTH by tumour tissue. The on September 26, 2021 by guest. Protected for a possible parathyroid adenoma. While the level development of hypercalcaemia and hypophos- of serum calcium was not life-threatening, the phataemia in patients with malignant neoplasms has residual kidney was at risk and its function could been reported. On the basis of histological studies, deteriorate if the hypercalcaemia persisted. At reasonably convincing evidence has been produced operation three parathyroid glands were identified. that a PTH-like substance can be formed in patients A mass removed from the right superior region of the with tumours and hypercalcaemia (Kohout, 1966).
Recommended publications
  • Primary Hyperparathyroidism and Celiac Disease: a Population-Based Cohort Study
    ORIGINAL ARTICLE Endocrine Care Primary Hyperparathyroidism and Celiac Disease: A Population-Based Cohort Study Jonas F. Ludvigsson, Olle Ka¨ mpe, Benjamin Lebwohl, Peter H. R. Green, Shonni J. Silverberg, and Anders Ekbom Department of Pediatrics (J.F.L.), O¨ rebro University Hospital, 701 85 O¨ rebro, Sweden; Clinical Epidemiology Unit (J.F.L., A.E.), Department of Medicine, Karolinska Institutet, 171 76 Stockholm, Sweden; Department of Medical Sciences (O.K.), Uppsala University, University Hospital, 751 85 Uppsala, Sweden; and Celiac Disease Center (B.L., P.H.R.G.), and Division of Endocrinology, Department of Medicine (S.J.S.), Columbia University College of Physicians and Surgeons, New York, New York 10032 Context: Celiac disease (CD) has been linked to several endocrine disorders, including type 1 dia- betes and thyroid disorders, but little is known regarding its association to primary hyperpara- thyroidism (PHPT). Objective: The aim of the study was to examine the risk of PHPT in patients with CD. Design and Setting: We conducted a two-group exposure-matched nonconcurrent cohort study in Sweden. A Cox regression model estimated hazard ratios (HR) for PHPT. Participants: We identified 17,121 adult patients with CD who were diagnosed through biopsy reports (Marsh 3, villous atrophy) from all 28 pathology departments in Sweden. Biopsies were performed in 1969–2008, and biopsy report data were collected in 2006–2008. Statistics Sweden then identified 85,166 reference individuals matched with the CD patients for age, sex, calendar period, and county. Main Outcome Measure: PHPT was measured according to the Swedish national registers on inpatient care, outpatient care, day surgery, and cancer.
    [Show full text]
  • Calcium and Parathyroid Disease
    created EXCLUSIVELY FOR FINANCIAL PROFESSIONALS Rx FOR SUCCESS Calcium and Parathyroid Disease The parathyroid glands are four small glands located in the thyroid gland, which lies by the larynx at the front of the neck. The parathyroid glands regulate the calcium level in the blood and calcium deposition in the bone. Hyperparathyroidism is an increase in parathyroid hormone (PTH) secretion and results in a high blood calcium level. Hypoparathyroidism is a decrease in PTH and causes low blood calcium. Primary hyperparathyroidism (PHPT) is caused by excessive secretion of parathyroid hormone from one or more parathyroid glands. 85% of cases are due to a small benign parathyroid adenoma. The remaining cases are due to multiglandular disease (called parathyroid hyperplasia) or to malignancy. Most hyperparathyroidism is diagnosed in asymptomatic people by an incidental finding of elevated serum calcium. Most persons with PHPT have an elevated parathyroid hormone (PTH). Parathyroid related symptoms include osteoporosis (bone thinning), kidney stones, peptic ulcer, mental changes (fatigue, depression, confusion), loss of appetite, nausea, vomiting, constipation, EKG changes, and arrythmias. Surgery is the usual treatment but carries with it the risk of damage to the recurrent laryngeal nerve. Recurrence occurs in a small percentage of patients. Secondary hyperparathyroidism is characterized by an elevated PTH and a low or low-normal serum calcium. The most common cause is chronic renal failure. Other causes are vitamin D deficiency and renal hypercalciuria. Hypoparathyroidism is usually due to accidental removal of the parathyroid glands during thyroid surgery or removal of too much parathyroid tissue during surgery for hyperparathyroidism. It is characterized by low serum calcium levels and increased levels of blood phosphorus (hyperphosphatemia).
    [Show full text]
  • Parathyroid Carcinoma Presenting As Tertiary Hyperparathyroidism
    Postgrad Med J: first published as 10.1136/pgmj.61.713.243 on 1 March 1985. Downloaded from Postgraduate Medical Journal (1985) 61, 243-244 Parathyroid carcinoma presenting as tertiary hyperparathyroidism D.J. Sherlockl*, J. Newman2 and R.T.J. Holl-Allen' Departments of 'Surgery and 2Pathology, East Birmingham Hospital, Bordesley Green East, Birmingham B9 SST, UK. Summary: A case of malignant transformation in established secondary hyperparathyroidism presenting as tertiary hyperparathyroidism is reported. Althougb rare, this occurrence has important medical and surgical implications. Introduction A case of malignant transformation in established At operation a large hard 4.0cm x 2.0 cm gland was secondary hyperparathyroidism is reported; this removed from the left upper pole adherent firmly to presented as tertiary hyperparathyroidism and the the thyroid gland. The other three glands were re- histology is discussed. This case would appear to moved also, a portion of one being autotransplanted. support the concept of malignant transformation Histological examination indicated that the large occurring in benign parathyroid disease. Although gland was carcinoma. The tumour invaded the cap- rare, this predisposition has important implications, sule, thyroid gland and a few small veins (Figure 1). especially for borderline cases treated conservatively Focally it had a trabecular structure and showed copyright. at present. cytological pleomorphism together with a number of mitoses. The remaining three glands displayed nodular hyperplasia. Case report The serum calcium fell rapidly post-operatively, requiring administration of intravenous calcium A 42 year old dialysis patient with increasing hypercal- gluconate on several occasions. She remains well one caemia was referred for parathyroidectomy in early year post-surgery, and has been maintained on 1983.
    [Show full text]
  • Hypercalcemia Secondary to Parathyroid Hormone Secretion from Metastatic Lesions in Liver
    Medical Case Studies Vol. 3(1), pp. 1-3, January 2012 Available online at http://www.academicjournals.org/MCS DOI: 10.5897/MCS11.026 ISSN 2141-6532 ©2012 Academic Journals Case Report Hypercalcemia secondary to parathyroid hormone secretion from metastatic lesions in liver Jennifer R. Dubay1, Veena Patil1, Neha Rickson1, Anthony Morrison2 and David L. Vesely1* 1James A. Haley Veterans Medical Center-151, 13000 Bruce B. Downs Blvd. Tampa, Florida 33612, USA. 2University of South Florida Health Sciences Center, Tampa, Florida 33647 USA. Accepted 30 November, 2011 Parathyroid cancer is a rare malignancy with a prevalence of 0.005% of all registered cancer cases in the United States. Metastases are rare but when they occur the metastatic lesions are usually in the lungs and lymph nodes. There has been only one reported metastasis to the liver in the 233 combined year experience of several major medical centers. A 35-year-old man had 9 metastatic lesions in his liver which produced approximately 1500 mg/dl PTH and sustained hypercalcemia (12.3 mg/dl) even after surgical resection of the parathyroid cancer and a transient hypocalcemia. Key words: Hypercalcemia, parathyroid hormone, liver secretion, metastases, parathyroid cancer. INTRODUCTION Parathyroid cancer is a rare endocrine malignancy with a This is the first case of a parathyroid cancer metastasis to prevalence of 0.005% of all registered cancer cases in liver that produced functional parathyroid hormone (PTH) the United States (Hundahl et al., 1999). It is also an and hypercalcemia. It is, thus, important to remember uncommon cause of hypercalcemia in persons with that hypercalcemia secondary parathyroid disease may parathyroid disease with only 0.4 to 3% of patients with not involve lesions in the neck but lesions elsewhere.
    [Show full text]
  • Spontaneous Healing of Osteitis Fibrosa Cystica in Primary Hyperparathyroidism
    754 Gibbs, Millar, Smith Postgrad Med J: first published as 10.1136/pgmj.72.854.754 on 1 December 1996. Downloaded from Spontaneous healing of osteitis fibrosa cystica in primary hyperparathyroidism CJ Gibbs, JGB Millar, J Smith Summar biochemistry showed hypercalcaemia, hypo- A 24-year-old man with primary hyper- phosphataemia, elevated parathyroid hormone, parathyroidism and osteitis fibrosa cystica but normal alkaline phosphatase (table). developed acute hypocalcaemia. Sponta- Radiographs showed improvement in the neous healing of his bone disease was mandibular translucency and resolution of the confirmed radiographically and by correc- phalangeal tuft resorption and subperiosteal tion of the serum alkaline phosphatase. erosion (figures 1B, 2B). Thallium scan of the Hypercalcaemia associated with a raised neck showed no evidence of parathyroid serum parathyroid hormone recurred 90 activity and neck exploration failed to reveal weeks after the initial presentation. Dur- any parathyroid tissue. Venous sampling ing the fourth neck exploration a para- showed no step-up in parathyroid hormone thyroid adenoma was removed, resulting concentration in the neck or chest. Selective in resolution of his condition. Haemor- angiography suggested a parathyroid adenoma rhagic infarction of an adenoma was the behind the right clavicle but two further most likely cause of the acute hypocalcae- explorations revealed only one normal para- mic episode. thyroid gland. Computed tomography (CT) of the neck showed a low attenuation, non- Keywords: primary hyperparathyroidism, osteitis enhancing mass in the right lower pole of the fibrosa cystica, hypercalcaemia thyroid gland. Ultrasonography confirmed a hypo-echoic mass 1.5 x 0.5 cm in the right lobe of the thyroid.
    [Show full text]
  • Osteomalacia and Hyperparathyroid Bone Disease in Patients with Nephrotic Syndrome
    Osteomalacia and Hyperparathyroid Bone Disease in Patients with Nephrotic Syndrome Hartmut H. Malluche, … , David A. Goldstein, Shaul G. Massry J Clin Invest. 1979;63(3):494-500. https://doi.org/10.1172/JCI109327. Research Article Patients with nephrotic syndrome have low blood levels of 25 hydroxyvitamin D (25-OH-D) most probably because of losses in urine, and a vitamin D-deficient state may ensue. The biological consequences of this phenomenon on target organs of vitamin D are not known. This study evaluates one of these target organs, the bone. Because renal failure is associated with bone disease, we studied six patients with nephrotic syndrome and normal renal function. The glomerular filtration rate was 113±2.1 (SE) ml/min; serum albumin, 2.3±27 g/dl; and proteinuria ranged between 3.5 and 14.7 g/24 h. Blood levels of 25-OH-D, total and ionized calcium and carboxy-terminal fragment of immunoreactive parathyroid hormone were measured, and morphometric analysis of bone histology was made in iliac crest biopsies obtained after double tetracycline labeling. Blood 25-OH-D was low in all patients (3.2-5.1 ng/ml; normal, 21.8±2.3 ng/ml). Blood levels of both total (8.1±0.12 mg/dl) and ionized (3.8±0.21 mg/dl) calcium were lower than normal and three patients had true hypocalcemia. Blood immuno-reactive parathyroid hormone levels were elevated in all. Volumetric density of osteoid was significantly increased in three out of six patients and the fraction of mineralizing osteoid seams was decreased in all.
    [Show full text]
  • Primary Hyperparathyroidism
    A FOCUS MEETING REPORT FROM: 2nd Expert Workshop on Parathyroid Disorders 27-28 June 2019, Santpoort, The Netherlands PARAT Steering Group: Jens Bollerslev (Norway) Claudio Marcocci (Italy) Lars Rejnmark (Denmark) Camilla Schalin-Jäntti (Finland) Wim Van Hul (Belgium) PARAT Expert Meeting Faculty: Bart L. Clarke (USA) Neil Gittoes (UK) Ghada El-Hajj Fuleihan (Lebanon) Hans Morreau (The Netherlands) Stefan Pilz (Austria) Lars Rolighed (Denmark) Heide Siggelkow (Germany) Antonio Sitges-Serra (Spain) Rajesh Thakker (UK) FREE access to presentation summaries and slide decks at: www.ese-hormones.org/ parat Calcium and Bone Contents Contents What is PARAT? | Steering Group 3 Faculty 2019 4 Participants 2019 5 Special Inherited Forms of Parathyroid Dysfunction 6 Inherited Forms of Primary Hyperparathyroidism (MEN1,2,4, HPT-JT and FIHP): Diagnosis and Management Camilla Schalin-Jantti, Finland CaSR-mutations (FHH – ADH): Genetic and Clinical Perspective, Ghada El-Hajj Fuleihan, Lebanon 7 PTH-receptor Mutation (PseudoHypoPT, Acrodysostosis), Lars Rejnmark, Denmark 8 Breakout Summary 9 Special Aspects of Hypoparathyroidism and Hyperparathyroidism 11 Management of Hypoparathyroidism during Pregnancy, Bart L. Clarke, USA Bone Metabolism and Fractures in Chronic Hypoparathyroidism in Adults, Jens Bollerslev, Norway 12 How to Avoid Surgical Damage to the Parathyroid Glands: 13 Part I: Current Best Practice. Antonio Sitges-Serra, Spain Part II: Prospective Techniques. Lars Rolighed, Denmark Breakout Summary 14 Primary and Secondary HPT and Atypical Adenomas 16 Atypical Parathyroid Adenoma Management Part I: Definitions and Characteristics. Claudio Marcocci, Italy Part II: A Diagnostic View. Hans Morreau, The Netherlands Secondary Hyperparathyroidism: Causes, Consequences and Non-Surgical Management. 18 Stefan Pilz, Austria Primary Hyperparathyroidism – NICE Guidelines.
    [Show full text]
  • Vitamin D and Primary Hyperparathyroidism (PHPT)
    Disponible en ligne sur www.sciencedirect.com Annales d’Endocrinologie 73 (2012) 165–169 Review Vitamin D and primary hyperparathyroidism (PHPT) Vitamine D et hyperparathyroïdie primitive (HPP) a,∗,b,c a,b,c d c,e Jean-Claude Souberbielle , Frank Bienaimé , Etienne Cavalier , Catherine Cormier a Service d’explorations fonctionnelles, laboratoire d’explorations fonctionnelles, hôpital Necker–Enfants-Malades, 149, rue de Sèvres, 75015 Paris, France b Centre de recherche croissance et signalisation (Inserm U845), faculté de médecine, hôpital Necker–Enfants-Malades, 149, rue de Sèvres, 75015 Paris, France c Université Paris Descartes, 45, rue des Saints-Pères, 75005 Paris, France d Service de chimie clinique, CHU de Liège, avenue de l’hôpital, 4000 Liège, Belgium e Service de rhumatologie, hôpital Cochin, AP–HP, 27, rue du Faubourg-Saint-Jacques, 75014 Paris, France Abstract Vitamin D deficiency and primary hyperparathyroidism (PHPT) are two common conditions, especially in postmenopausal women. Vitamin D deficiency is said to be even more frequent in PHPT patients than in the general population due to an accelerated conversion of 25-hydroxy vitamin D (25OHD) into calcitriol or 24-hydroxylated compounds. Although several studies have reported worsening of PHPT phenotype (larger tumours, higher parathyroid hormone [PTH] levels, more severe bone disease) when vitamin D deficiency coexists whereas vitamin D supplementation in PHPT patients with a serum calcium level less than 3 mmol/L has been shown to be safe (no increase in serum or urinary calcium) and to decrease serum PTH concentration, many physicians are afraid to give vitamin D to already hypercalcemic PHPT patients. It is possible that, in some patients, a persistent vitamin D deficiency induces, in the long-term, an autonomous secretion of PTH (i.e.
    [Show full text]
  • Primary Hyperparathyroidism
    Primary Hyperparathyroidism National Endocrine and Metabolic Diseases Information Service What is primary What are the parathyroid hyperparathyroidism? glands? Primary hyperparathyroidism is a disorder The parathyroid glands are four pea-sized U.S. Department of the parathyroid glands, also called glands located on or near the thyroid gland of Health and parathyroids. “Primary” means this disorder in the neck. Occasionally, a person is born Human Services originates in the parathyroid glands. In with one or more of the parathyroid glands primary hyperparathyroidism, one or more in another location. For example, a gland NATIONAL INSTITUTES of the parathyroid glands are overactive. may be embedded in the thyroid, in the OF HEALTH As a result, the gland releases too much thymus—an immune system organ located parathyroid hormone (PTH). The disorder in the chest—or elsewhere around this area. includes the problems that occur in the rest In most such cases, however, the parathyroid of the body as a result of too much PTH—for glands function normally. example, loss of calcium from bones. In the United States, about 100,000 people develop primary hyperparathyroidism each year.1 The disorder is diagnosed most often in people between age 50 and 60, and women are affected about three times as often as men.2 Secondary, or reactive, hyperparathyroidism can occur if a problem such as kidney failure causes the parathyroid glands to be overactive. Parathyroid glands Thyroid gland The parathyroid glands are located on or near the thyroid gland in the neck. 1Bilezikian JP. Primary hyperparathyroidism. In: DeGroot LJ, ed.; Arnold A, section editor.
    [Show full text]
  • Primary Hyperparathyroidism General PHPT Information Page from Or If You Are Below the Age of 50 Then Surgery Will Hypoparathyroidism UK Normally Be Advised
    What will the doctor do? What happens in the long-term? Primary When PHPT is diagnosed your doctor will assess the PHPT is normally curable with surgery and you should risks to you due to the condition. You will have blood expect to resume a normal life after surgery. If surgery Hyperparathyroidism and urine tests to see what the level of calcium is in is not advised, or if you decide not to have surgery, the blood and the urine and whether it has caused regular follow up visits will be needed to make sure you any harm. You will be asked if you have had the level of calcium does not increase and to see if you Information Sheet kidney stones or have fractured any bones. A DXA have developed any new problems due to the PHPT. scan, that measures your bone density, might be You will also be given lifestyle advice such as to avoid By Dr Mark Cooper on Behalf of the Society for arranged as may a scan of your kidneys. You will also dehydration, to continue to take a reasonable level of Endocrinology Bone and Mineral Special Interest Group be asked whether anyone else in your family has had a calcium in your diet and to seek medical help if you problem with their parathyroid glands as PHPT can develop persistent vomiting and diarrhoea. occasionally be inherited from your parents. Your doctor will also discuss the best way to deal with Further information/useful websites: This information sheet is for people your PHPT. As stated above, if your level of calcium is very high, if you have symptoms from the high calcium who have primary hyperparathyroidism General PHPT information page from or if you are below the age of 50 then surgery will Hypoparathyroidism UK normally be advised.
    [Show full text]
  • Tertiary Hyperparathyroidism
    17 August 1968 British Medicine in Australia-Rieger ,B~ff 395 We in Australia, after 15 years of running repairs and alter- doubt have exhorted us to continue our efforts to achieve a ations, have a vehicle in need of a major overhaul. Like you national registration board. Lister would have experienced Br Med J: first published as 10.1136/bmj.3.5615.395 on 17 August 1968. Downloaded from in Britain, our difficulties are basically those of finance, how great satisfaction in the progress of surgery. Osler would best to obtain and apply this to provide all members of the doubtlessly have regarded our progress in the control of medical community with complete cover. practice with " equanimity." It has become apparent that our ideas on the basic philosophy All three would assuredly survey the advances of science and of national health care are again approximating, and that our technology with amazement, and we trust they would approve paths, at present as antipodean as our countries, are converging. the progress made towards maturity, and promised in our Both our countries can gain much from each other in their " vigorous infancy," of " British Medicine in Australia." efforts to provide, on a national scale, readily available medical When the time arrives for your return to your homes we care of the highest standard. This we shall both achieve if all hope that you will take with you many happy memories of concerned approach the task with open minds, actuated by your stay in this land of Australia, new friendships, and an the highest motives, basing their decisions on facts and dili- enhanced knowledge and appreciation of our country, its gently pursuing one common purpose.
    [Show full text]
  • Secondary Hyperparathyroidism and Chronic Kidney Disease Mohammad Reza Tamadon*
    Open Access http://www.jparathyroid.com Journal of Journal of Parathyroid Disease 2013,1(1),15–16 Epidemiology and Prevention Secondary hyperparathyroidism and chronic kidney disease Mohammad Reza Tamadon* ne of the chronic kidney disease complications, Implication for health policy/practice/research/ is secondary hyperparathyroidism. The medical education development of secondary hyperparathyroidism Secondary hyperparathyroidism is a frequently Oresults from various factors, including deficiency encountered problem in the management of patients of calcitriol, retention of phosphorus, a decrease in with chronic kidney disease. Its pathophysiology the activation of the calcium-sensing receptor in the is mainly due to hyperphosphatemia and vitamin parathyroid gland, and skeletal resistance to the calcemic D deficiency and resistance. This situation has a effects of parathormone. As kidney function declines, high impact on the mortality and morbidity of so does phosphorus excretion, thus causing plasma dialysis patients. Prompt diagnosis of secondary phosphorus levels to rise while plasma calcium and hyperparathyroidism is crucial in the management of calcitriol levels decrease. A reduction in calcitriol also patients with chronic kidney disease. The treatment contributes to a reduction in intestinal calcium absorption. remains a challenge for patients and their clinicians. It All of these factors contribute to the development of would comprise a combination of dietary phosphorus hypocalcemia, which is the motivation for an increased restriction, phosphate binders, calcimimetics and production of parathormone (1). vitamin D analogues. Several studies have assessed the relation of hyperparathyroidism in dialysis patients with other risk factors. In these studies, the relationship between a number of serious complications, including increased malnutrition and inflammatory processes and incidence of cardiovascular disease, hyperlipidemia, cardiovascular complications in dialysis patients are anemia and metabolic bone disease.
    [Show full text]